Published in:
Open Access
01-12-2018 | Letter
Gender differences in the use of atypical antipsychotic medications for ICU delirium
Authors:
Kunal Karamchandani, Robert S. Schoaps, Jillian Printz, Jeffrey M. Kowaleski, Zyad J. Carr
Published in:
Critical Care
|
Issue 1/2018
Login to get access
Excerpt
Intensive care unit (ICU) delirium, an acute fluctuating disturbance of cognition associated with critical illness, is associated with increased mortality, ICU length of stay, mechanical ventilation, and hospital costs [
1‐
3]. Despite a link to increased long-term mortality, atypical antipsychotic medications (AAP) are frequently administered for the treatment of ICU delirium. Males have a higher risk of being diagnosed with ICU delirium (63% vs 36%) and being initiated on AAP (44% vs 40%) compared to females [
4,
5]. …